Prescription drug · ANDA
Lanreotide Acetate NDC 70121-2517
Lanreotide acetate 120 mg/.5mL · Injection · Subcutaneous · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70121-2517-5 | 7012125170570121251705 | 1 POUCH in 1 CARTON (70121-2517-5) / 1 SYRINGE, PLASTIC in 1 POUCH / .5 mL in 1 SYRINGE, PLASTICMarketed from Sep 23, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lanreotide Acetate
- Generic name (nonproprietary)
- lanreotide acetate
- Active ingredients
- Lanreotide acetate — 120 mg/.5mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- Amneal Pharmaceuticals LLCNDC labeler code 70121
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218217
- Marketing start
- Listing expires
- Other FDA classes
- Somatostatin Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70121-2517_43b3c820-dda0-4514-92cd-3ad85019d105SPL ID 43b3c820-dda0-4514-92cd-3ad85019d105
- Pharmacologic class
- Somatostatin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470121251705followed by a unit qualifier and the quantityPackage 70121-2517-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70121-2517
- What is NDC 70121-2517?
- 70121-2517 is the product NDC for Lanreotide Acetate, Lanreotide acetate 120 mg/.5mL injection, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lanreotide Acetate.
- What is the active ingredient?
- Lanreotide acetate.
- Who is the labeler?
- Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lanreotide Acetate?
- 9 other product NDCs are listed under this name. See all Lanreotide Acetate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lanreotide Acetate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-906 | 69097-0906-67 |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-907 | 69097-0907-67 |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-908 | 69097-0908-67 |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | EXELAN PHARMACEUTICALS, INC. | 76282-718 | 76282-0718-67 |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | EXELAN PHARMACEUTICALS, INC. | 76282-719 | 76282-0719-67 |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | EXELAN PHARMACEUTICALS, INC. | 76282-720 | 76282-0720-67 |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-870 | 69097-0870-67 |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-880 | 69097-0880-67 |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | Cipla USA Inc. | 69097-890 | 69097-0890-67 |